ANEURX
Report
- Report Number
- 2953200-2014-00586
- Event Type
- Malfunction
- Date Received
- March 25, 2014
- Date of Event
- January 1, 2013
- Report Date
- March 7, 2014
- Manufacturer
- MEDTRONIC CARDIOVASCULAR
- Product Code
- MIH
- PMA / PMN Number
- P990020
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4).
THE FOLLOWING INFORMATION WAS OBTAINED FROM A JOURNAL ARTICLE. VASCULAR ENDOSTAPLING SYSTEMS FOR VASCULAR ENDOGRAFTS (T)EVAR-SYSTEMATIC REVIEW-CURRENT STATE BAIL, D., WALKER, T., GIEHL, J. VASCULAR AND ENDOVASCULAR SURGERY 2013 47(4) 261-266 DOI: 10.1177/1538574413478474 ABSTRACT PURPOSE: RECENTLY, VASCULAR ENDOSTAPLING SYSTEMS WERE DEVELOPED TO ACHIEVE BETTER SEALING AT THE PROXIMAL NECK OF THE ANEURYSM AND TO PREVENT ENDOGRAFT MIGRATION. THE PURPOSE OF THIS STUDY WAS TO PROVIDE A SYSTEMATIC REVIEW ABOUT THE CURRENT STATE AND POSSIBLE OPTIONS OF VASCULAR ENDOSTAPLING SYSTEMS. RESULTS: NO RANDOMIZED CONTROLLED TRIALS WERE PUBLISHED. THE RESULTS SHOWED THAT THE USE OF AN ENDOSTAPLE SYSTEM CONSIDERABLY REDUCED THE RATES OF ENDOLEAKS TYPE 1A AND ENDOGRAFT MIGRATION. REGARDING THE USE OF ENDOSTAPLES IN DIFFERENT TYPES OF ENDOGRAFTS, ONLY A FEW RESULTS WERE AVAILABLE. CONCLUSION: THE RESULTS ARE NOT CONCLUSIVE. WITH ENDOSTAPLE SYSTEMS, PATIENTS WITH DIFFICULT ANATOMIC FEATURES AND HIGH RISK CAN POTENTIALLY BE TREATED. THESE SYSTEMS MIGHT REDUCE THE HIGH REINTERVENTION RATES AFTER ENDOVASCULAR ANEURYSM REPAIR. CONTROLLED RANDOMIZED TRIALS WITH LARGER NUMBER OF PATIENTS ARE WARRANTED WITH ENDOSTAPLING USE IN PRIMARY ENDOGRAFT IMPLANTATION AND FOR USE IN REINTERVENTION FOR LATE ENDOLEAKS OR ENDOGRAFT MIGRATIONS. THE FOLLOWING EVENTS WERE REPORTED: STENT GRAFT MIGRATION, ENDOLEAK.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 175151 | ANEURX | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | MEDTRONIC CARDIOVASCULAR |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |